"Designing Growth Strategies is in our DNA"

External Defibrillator Market Size, Share and Industry Analysis By Product (Automated External Defibrillator (AED), Manual and Semi-automatic External Defibrillator, Wearable External Defibrillator), By End User (Hospitals & Clinics, Schools and other Public Places), and Regional Forecast 2026-2034

Last Updated: April 20, 2026 | Format: PDF | Report ID: FBI100949

 

External Defibrillator Market Size and Industry Analysis

Play Audio Listen to Audio Version

The global external defibrillator market size was valued at USD 4.69 billion in 2025. The market is projected to grow from USD 5.21 billion in 2026 to USD 12.10 billion by 2034, exhibiting a CAGR of 11.11% during the forecast period. North America dominated the external defibrillator market with a market share of 53.63% in 2025. 

An external defibrillator is a portable electronic device that is utilized to detect and treat cardiac arrhythmia (pulseless ventricular tachycardia and ventricular fibrillation) with the help of electric impulses. Rapidly growing prevalence of sudden cardiac arrests, increasing product awareness amongst population and benefits offered by external defibrillators are expected to boost the adoption of external defibrillators during the forecast period.

Download Free sample to learn more about this report.

According to a research conducted by the Sudden Cardiac Arrest Foundation (SCAF) in 2018, an estimated 356,000 people suffer from out-of-hospital cardiac arrest (OHCA) each year in the U.S. Moreover, increasing prevalence of congenital heart disease, obesity, diabetes, smoking, and high blood pressure are expected to boost the prevalence of sudden cardiac arrest, which can result into increased adoption of external defibrillators during the forecast period. 

"Superior Ergonomics and Effective Treatment Outcomes of Wearable defibrillator are Expected to Boost the External Defibrillator Market Share and Growth "

In 2014, Asahi Kasei Corporation launched LifeVest, a wearable defibrillator in certain parts of the world. A wearable external defibrillator is programmed in such a way that; it can predict the risk of sudden cardiac arrest even before it occurs. Combined with this, automatic shock delivery with an aim to restore the heart rhythm and cost-effectiveness are anticipated to offer a favorable environment for the adoption of wearable defibrillators. At present, the availability of wearable external defibrillator is limited to certain countries. However, the projected global launch of wearable defibrillator by Asahi Kasei Corporation serves huge opportunity for the global external defibrillator market growth owing to benefits offered by the wearable defibrillator. Among the products, a wearable external defibrillator is expected to be the fastest-growing segment globally.

External Defibrillator Market

Download Free sample to learn more about this report.

External Defibrillator Industry Landscape Overview

Market Size & Forecast:

  • 2025 Market Size: USD 4.69 billion
  • 2026 Market Size: USD 5.21 billion
  • 2034 Forecast Market Size: USD 12.1 billion
  • CAGR: 11.11% from 2026–2034

Market Share:

  • North America dominated the external defibrillator market with a 53.63% share in 2025, driven by high installations of defibrillators in hospitals, schools, public places, and favorable government regulations including AED training initiatives.
  • By product, the automated external defibrillator (AED) held the largest market share at 45.9% in 2018, owing to cost-effectiveness, regulatory support, and ease of use.

Key Country Highlights:

  • Japan: Expected to benefit from Asahi Kasei’s expansion and innovations in wearable defibrillators as part of broader health tech advancements.
  • United States: An estimated 356,000 OHCA (Out-of-Hospital Cardiac Arrest) cases annually drive strong AED demand; combined with federal mandates for AED installations and training, it remains a key growth driver.
  • China: Rising incidence of heart disease and increasing healthcare investments suggest high future adoption, especially in urban hospitals and public infrastructure.
  • Europe: Growing emphasis on emergency preparedness and widespread deployment of AEDs in public areas support market growth across countries like Germany, UK, and France.

Segmentation Analysis

On the basis of product, the global external defibrillator market report includes segments as automated external defibrillator, manual & semi-automated external defibrillator and wearable external defibrillator. An automated external defibrillator held an estimated 45.9% in the global external defibrillator market share in 2018, owing to increasing adoption, favorable government regulations, and minimal costs. 

To know how our report can help streamline your business, Speak to Analyst

In terms of end users, the public places and others are expected to register comparatively higher global market share owing to higher installations of automated external defibrillators (AEDs) in developed as well as emerging nations.

Regional Analysis

"Higher Adoption of External Defibrillator Installations Across the U.S. Enables Market to Hold Considerable Share in North America"

North America

North America generated a revenue of US$ 1,690.6 Mn in 2018 and is expected to dominate the market throughout the forecast period. Growing installations of external defibrillators in hospitals, as well as public places such as schools, hotels, streets, railway stations, and others with an aim to prevent fatalities from sudden cardiac arrest, is prominently driving the growth of the North America external defibrillator market.

North America External Defibrillator Market Size, 2025

To get more information on the regional analysis of this market, Download Free sample

Moreover, favorable government regulations, the growing emphasis on AED training, and increasing awareness amongst people to treat out-of-hospital cardiac arrest are projected to boost the external defibrillator market sales in North America.

Key Market Drivers

"Asahi Kasei Corporation and Philips Healthcare to Hold More Than Half of the Market Share in Terms of Revenue"

Asahi Kasei Corporation is a leading player in the global external defibrillator market. The company is estimated to retain its position in the forecast duration owing to its diverse product offering in external as well as wearable defibrillator segment, efficient customer reach, and strong after-sales service. This company, together with Philips Healthcare, currently holds over half of the market share in terms of revenue. Other players operating in the global external defibrillator market are Cardiac Science, Physio Control, Stryker, Defibtech, LLC., CU Medical Systems Inc., and others.

List of Companies Profiled

  • Asahi Kasei Corporation
  • Philips Healthcare
  • Defibtech, LLC.
  • Cardiac Science
  • Stryker
  • CU Medical System Inc.
  • Other prominent players

Key Industry Developments:

  • August 28, 2024: At the European Society of Cardiology Congress, Philips showcased AI-enabled integrated solutions to deliver better cardiac care. These innovations aim to address challenges in cardiology, transforming the diagnosis and treatment of heart disease. 
  • June 12, 2024: Philips celebrated the milestone of shipping a total of two million automated external defibrillators (AEDs) worldwide. This achievement underscores the company's commitment to providing reliable, easy-to-use lifesaving technology. 
  • November 21, 2024: Asahi Kasei Electronics Corporation announced its participation in CES® 2025, where it plans to unveil advancements in health technology, including vital sensing and elderly monitoring solutions. While specific defibrillator products were not mentioned, the company's involvement in health tech innovations suggests a potential focus on cardiac care technologies. 

Report Coverage

Request for Customization   to gain extensive market insights.

External defibrillator offers an effective treatment option to deal with out-of-hospital cardiac arrest and arrhythmia. Automated external defibrillators detect arrhythmia and restore the patient’s heartbeats which can lead to fatal death. The rapidly increasing prevalence of out-of-hospital cardiac arrests and unmet demand in emerging nations along with favorable government regulations are expected to drive the global external defibrillator market revenue by 2026. 

The report provides qualitative and quantitative insights on the external defibrillator industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The external defibrillator market segments include product, end-user, and region. On the basis of the product, the market is segmented into an automated external defibrillator (AED), manual and semi-automatic external defibrillator, and wearable external defibrillator.

Various end-users covered under the report are hospitals & clinics and schools and other public places. Geographically, the global market is segmented into four major regions, which are North America, Europe, Asia Pacific, and the rest of the World. The regions are further categorized into countries. 

Along with this, the report analysis provides an elaborative analysis of the global external defibrillator market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of sudden cardiac arrests in key countries, technological advancements in external defibrillators industry, recent industry developments in the global market, such as mergers & acquisitions, the regulatory scenario in key countries, new products launches, reimbursement scenario, and key industry trends.

SEGMENTATION

 ATTRIBUTE

 DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Unit

Value (USD Billion)

Growth Rate

CAGR of 11.11% from 2026 to 2034

By Product

  • Automated External Defibrillator (AED)
  • Manual and Semi-Automatic External Defibrillator
  • Wearable External Defibrillator

By End User

  • Hospitals & Clinics
  • Schools and other Public Places

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Rest of the World


Frequently Asked Questions

Fortune Business Insights says that the Global External Defibrillator market was valued at USD 4.69 billion in 2025 and is projected to reach USD 12.1 billion by 2034.

In 2025, the market was valued at USD 4.69 billion.

Growing at a CAGR of 11.11%, the market will exhibit steady growth in the forecast period (2026-2034)

Automated External Defibrillator is expected to be the leading segment in this market during the forecast period.

Superior ergonomics and effective treatment outcomes of wearable defibrillator will drive the growth of the Global External Defibrillator market.

North America dominated the Global External Defibrillator market in 2018?

Asahi Kasei Corporation and Philips Healthcare are the top players in the market.

Increasing adoption, favorable government regulations, and minimal costs of Automated External Defibrillator is estimated to drive the market.

Increasing shift towards adoption of wearable external defibrillator owing to the added benefits offered by the products are one the key trends of Global External Defibrillator Market.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 112
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann